ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2209

Transition From The Pediatric Rheumatologist To The Adult Rheumatologist: Outcomes Of 5 Years Of Experience Between Two Institutions

Elizabeth C. Ortiz1, Agarwal Arunima2, Sandra Mintz3 and Bracha Shaham4, 1Rheumatology, University of Southern California, Los Angeles, CA, 2Division of Rheumatology, Childrens Hospital Los Angeles, Los Angeles, CA, 34650 Sunset Boulevard, Mailstop 60, Children's Hospital of LA, Los Angeles, CA, 4Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Transition and pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Title: ARHP Pediatrics

Session Type: Abstract Submissions (ARHP)

Background/Purpose: It is well documented that children with rheumatologic conditions are living into adulthood and require transition of care into the adult medical center. This process is frequently met with a number of barriers that require programs and processes to address the issues for successful transfer of care.  Children’s Hospital Los Angeles (CHLA) and the Los Angeles County+University of Southern California Medical Center (LAC+USC MC) decided to collaborate to meet this need. The objective of this study is to evaluate the transfer success rate and length of time from last pediatric appointment to the adult setting. In addition, whether the adherence rates prior to transition correlated with the attendnce rate in the adult setting and identify trends between diagnosis and compliance history while at CHLA.

Methods: Retrospective review of charts from patients scheduled to transfer care from 2008-2013 were reviewed.  Patients identified were either without medical coverage or with state-funded Medi-Cal, as these patients require transfer of care to the LAC+USC MC. Demographic data, diagnosis, adherence to pediatric appointments and adherence to adult appointments were noted.

Results: 131 patients were to transfer care from CHLA to USC+LAC MC from fall 2008-spring 2013. There were 103 women, 28 men. Diagnosis included SLE (58), JIA (36), AS (10), MCTD (6), Dermatomyositis (4), Scleroderma (4), Psoriatic arthritis (3), Vasculitis (5), FMF and Sjogrens (1 each) and other (3). Fifty-nine patients (45%) were never seen at LAC+USC MC, while 72 (55%) attended their provided appointment.  The mean time from the last CHLA appointment to the first LAC+USC MC appointment was 179.7 days (range: -12 to 1614 days). Adherence with pediatric appointments within the last year of treatment was defined as good (no missed appointments), fair (1-2 missed appointments), or poor (3+ missed appointments). Thirty-two (41.6%) of the 77 patients with good adherence to pediatric appointments were not seen at LAC+USC MC, 26 (55.3%) of 47 patients with fair adherence, and 1 (14.3%) patient of 6 patients with poor adherence. Mean time from last CHLA appointment to first LAC+USC MC appointment for those with good, fair or poor adherence was 97.2 days, 289.5 days, 359.8 days, respectively.  Seventeen (47.2%) of 36 patients with JIA did not transfer care to LAC+USC MC, 25 (43.1%) of 58 patients with SLE. The mean time from last CHLA appointment to first LAC+USC MC appointment for those with JIA and SLE were 206.2 days and 217.4 days, respectively.

Conclusion: There are many obstacles to a successful transition from the pediatric to the adult rheumatologist. This data shows, despite having an identified appointment, only 55% of patients successfully transferred care. In addition, of those who demonstrated poor appointment compliance at CHLA, most attended their LAC+USC MC. From our data, it is clear there is work to be done as only half of those requiring transfer of care to LAC+USC MC are seen and many of those after a substantial gap in their care.  A large-scale, prospective study of patients during this time period could further elucidate the reasons for these observations and identify areas for improvment.


Disclosure:

E. C. Ortiz,
None;

A. Arunima,
None;

S. Mintz,
None;

B. Shaham,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transition-from-the-pediatric-rheumatologist-to-the-adult-rheumatologist-outcomes-of-5-years-of-experience-between-two-institutions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology